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INTRODUCTION
High-risk human papillomavirus (HPV) plays a necessary role in the development of cervical cancer, which is the third most common cancer in women worldwide. 1 Among the 15 HPV types classified as high-risk, HPV16 and HPV18 are the two most important types accounting for about 70% of cervical cancers across the world. The remaining cancers are caused by HPV31, 33, 35, 39, 45, 51, 52, 56, 58
and 59. The distribution of these less common types shows some degree of ethnogeographical variation. 2, 3 HPV58 is an uncommon type with skewed ethnogeographical distribution. The prevalence of HPV58 is remarkably high among cervical squamous cell carcinomas in East Asia (33% in Shaanxi, 26% in Shanghai, 16% in South Korea, 10% in Hong Kong and Taiwan, and 8% in Japan), [4] [5] [6] [7] [8] [9] whereas it only accounts for about 2% of cervical cancers in other regions. 2, 3 In addition to East Asia, a higher prevalence of HPV58 has also been observed in a few places in Latin America. HPV58 was found in 12% of cervical cancers in Costa Rica, 10 21% in Southeastern Mexico, 11 9 .5% in Northeastern Brazil, 12 and was the second most common type (about 13%) found in precancerous lesions in Central and Southern Brazil. 13, 14 The reason for an ethnogeographical predilection in the attribution of HPV58 to cervical cancer is not fully understood. HPV58 variants are classified into four lineages. These lineages exhibit a distribution pattern that varies across the world. 15, 16 Studies comparing the risk association of these variant lineages are very limited and a conclusion has not yet been reached. 17, 18 The E6 and E7 proteins encoded by high-risk HPV play a key role in cellular transformation.
Previous studies from Eastern 19 and Southern Chinese populations 20 suggested that sequence variations within these regions may be associated with a higher risk for cervical neoplasia. At present, information on sequence variation of the E6 and E7 open reading frames (ORF) of HPV58 8 have been derived mainly from Chinese populations. [18] [19] [20] The current study examined the sequence polymorphisms of HPV58 E6 and E7 ORF and assessed the geographical distribution and risk association with cervical neoplasia from a global perspective.
MATERIALS AND METHODS
Study Samples
A total of 401 samples including 295 cervical scrapes or swabs, 69 vaginal swabs and 37 anal samples collected from 15 countries and cities were examined in this study (Table 1 ). These samples have been used to establish a lineage classification system for HPV58 variants.
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Nucleotide Sequencing
The full length of E6 and E7 ORF was amplified by polymerase chain reaction (PCR) using primers 5'-CGA AAA CGG TCT GAC CGA AA-3' and 5'-TAT CGT CTG CTG TTT CGT CC-3', followed by a second PCR using inner primers (5'-GAC CGA AAC CGG TGC ATA TA-3' and 5'-ACC GCT TCT ACC TCA AAC CA-3') when necessary. Briefly, the PCR was conducted in a 50-µL reaction mix containing 4 μL of extracted 
Phylogenetic Analysis
The program MEGA5 was applied to identify the best evolutionary model and to construct the maximum-likelihood trees using the close-neighbor-interchange (CNI) search approach. 21 The data were bootstrap resampled 1,000 times for tree topology evaluation. HPV33 was used as an outgroup sequence. The program Datamonkey (http://www.datamonkey.org) was used to detect positive or negative selection.
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Statistical Analysis
All data analyses were performed by the Statistical Package for Social Sciences (version 18.0.0, IBM Corp. NY). The rate of detection of E6 and E7 sequence patterns was compared between the four regions by chi-squared test and using the Bonferroni method to account for multiple comparisons. 24 For the purpose of risk association analysis, women with normal cytology or absence of lesion at colposcopy or biopsy were grouped as "normal cervices". Using cervical intraepithelial neoplasia grade III (CIN3) and cervical cancer as an outcome variable and "normal cervices" as control, the risk association of non-synonymous substitutions was first assessed by univariate analysis using chisquared test or Fisher's exact test. Those mutations found to be significant for the association (p<0.05) were tested for interactions, followed by unconditional binary logistic regression analyses 10 controlling for patients' age and their country of origin. All P values <0.05 were regarded as statistically significant.
This study has included 37 anal samples collected from men in the United States of America.
In our previous study on HPV58 variant lineage based on the same cohort of samples, no differences in the distribution of variants between these anal samples and cervical samples collected from the same region was observed. 16 In this study, there were also no differences in the distribution of E6 and E7 variants among these two sources of samples. For these reasons, anal samples were pooled together with cervical samples for the purpose of analysis in this study.
RESULTS
E6 Sequence Variation
Altogether, 19 variants showing nucleotide sequence variations in the E6 ORF were identified ( Figure   1 ). The maximum variation between any two variants was nine nucleotides, a variability of 2.0% over the 450-bp E6 ORF. The mean dN/dS was 0.916 and no site with significant positive or negative selection was found. Altogether, 16 nucleotide positions showing sequence polymorphism were identified, with 11 positions had non-synonymous substitutions leading to amino acid changes. Based on the phylogenetic relationship, the E6 sequence patterns could be classified into four groups designated as E6-A, -B, -C, and -D; and each group was associated with a signature nucleotide sequence variation as shown in Figure 2A . The maximum inter-group nucleotide sequence variability ranging from 0.9% (E6-A and -B) to 2.0% (E6-B and -D), whereas the maximum intra-group variability ranging from 0.7% (E6-A and -C) to 1.3% (E6-B). The phylogenetic relationship and their associated signature nucleotide sequence variations are shown in Figure 2B .
E7 Sequence Variation
Geographical Distribution
The frequencies of different E6 and E7 sequence variation patterns among isolates collected from different parts of the world are shown in Figure 4 . E6-A was the most common pattern found overall ( Figure 4A ). In Asia, Americas and Europe, E6-A predominated and accounted for 86-96% of isolates.
In Africa, E6-A (51%) co-circulated with E6-C (40%). E6-A was significantly less frequent in Africa compared to the other three regions (P = 0.003 for Americas, P < 0.001 for Asia and Europe); whereas E6-C was significantly more frequent in Africa than in other regions (P < 0.001 for all 3 regions).
The geographical distribution of E7 sequence patterns was more diverse ( Figure 4B ). In Asia, both E7-B and E7-C patterns were commonly found; whereas E7-B and E7-D patterns co-dominated in Africa. E7-C was significantly more frequent in Asia (P < 0.001 for all three regions); whereas E7-D was significantly more frequent in Africa (P < 0.001 for all three regions).
Risk Association with Cervical Neoplasia
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Among the 401 samples examined, 33 were histology-confirmed invasive cervical cancer, 31 were CIN3, and 79 were normal cervices as defined by normal cytology or no lesion detected at colposcopy or biopsy. These cases were used to analyze the risk association of sequence variations. Two E7 substitutions (G41R and G63D) showed a significantly lower risk, and the other two E7 substitutions (G63S and T20I) showed a significantly higher risk based on univariate analysis ( Table 2 ). All isolates with G41R also carried G63D, and a significant interaction was found (P = 0.023). Similarly, all isolates with T20I also carried G63S, and a significant interaction was found (P = 0.002). We therefore selected G41R and T20I into two separate final regression models, respectively, controlling for age and country of origin. It was found that T20I and/or G63S conferred an independent increase in risk for CIN3 and invasive cervical cancer (adjusted odds ratio 4.44, 95% CI. 1.51-13.05, P = 0.007). The risk association observed for G41R and/or G63D was no longer significant after multivariate analysis.
Discussion
The current study has delineated the sequence variations of two oncoprotein-encoding genes of HPV58. This data set provides essential information for further in depth studies to elucidate the epidemiology of this characteristic HPV type that exhibits a higher disease attribution in certain ethnogeographical groups. While the current study has examined a large series of samples covering a wide range of geographical regions, one should note that the number of samples available from certain areas was small and might not be representative of those areas.
The degree of nucleotide sequence variation among HPV58 isolates was found to be small (maximum 2% for E6, 3% for E7), as expected for HPV in general. 15, [25] [26] [27] Phylogenetically related E6
and E7 sequence patterns could be identified by distinct signatures of non-synonymous sequence 13 variations. These molecular signatures not only provide convenient markers for large-scale epidemiological studies, but the substitutions themselves may carry biological implications.
Overexpression of E6 and E7 proteins is required to maintain the transformed phenotype of keratinocytes, and thus they are constitutively retained in cancer cells and not affected by viral genome disruption resulting from integration. Therefore, E6 and E7 are good diagnostic targets, particularly for type-specific detection as E6 and E7 genes are diverse among HPV types. Our results
show that the sequences of E7 were more variable than those of E6, and more heterogenously distributed across the world. This observation of HPV58 is in contrast to those reported for HPV16, 31, 33, 35 and 52 where the E7 ORF is less variable, and therefore E7 is often chosen as the target for diagnostic detection of HPV16. 28, 29 Based on the current findings, E6 rather than E7 is a better target for type-specific detection of HPV58.
The first clone of HPV58 was obtained from a Japanese patient with invasive cervical cancer.
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This strain is regarded as the prototype and commonly used for primer design. The E6-A2 and E7-A1 sequence pattern, as assigned by this study, corresponds respectively to the E6 and E7 sequence of the prototype. Our data showed that these "prototype-like" sequences were uncommon (10%) in Asia, and rare (< 3%) in other regions. Primers and probes designed based on the prototype sequence may have the problem of mismatch with the more commonly found strains.
Geographical predilection in the distribution of E6 and E7 sequence patterns was observed.
E6-A predominated in most parts of the world except Africa, where it co-dominated with E6-C that was uncommon elsewhere. Two characteristics in the distribution of E7 sequence variation patterns were observed. Firstly, E7-D with a nucleotide signature of 793G was a common sequence pattern found in 51% of isolates from Africa, but uncommon (14%) in Americas and rare in Asia (4%) and Europe (7%). The second observation was that E7-C with an amino acid substitution signature of T20I 14 and G63S was commonly found in Asia (34%) and Americas (11%), but rare elsewhere. Geographical variation in the distribution of HPV58 E6 and E7 sequence patterns should be considered in designing diagnostic assays.
HPV58 is rare worldwide but attributes to a higher proportion of cervical cancers in East Asia and some parts of Latin America. This study attempted to identify HPV58 E6 and E7 sequence variations that might carry a higher oncogenic risk, and examined whether the distribution of these variations could account for the ethnogeographical predilection in disease burden. Isolates carrying G63S and/or T20I were found to have an independent increase in risk for CIN3 and invasive cervical cancer. Only one variant harboured G63S alone without T20I. This variant was only found in four samples precluding analysis on these two amino acid variations separately.
The high-risk mutations T20I and G63S were found in 33% of isolates in Asia and 10% in Americas, but rare in Europe (3%) and Africa (0%). This distribution is reminiscent of the geographical predilection in cervical cancers associated with HPV58. A previous study from southern China (Hong Kong) also revealed that substitutions T20I and/or G63S were associated with a 6.9-fold increase in odds ratio for developing invasive cervical cancer, and the age of patients were significantly younger than those infected with other variants of HPV58. 20 Another study from eastern China (Zhejiang) also reported a significant positive trend of association between these substitutions and the severity of cervical lesions. 19 It has been shown that HPV58 variants can be divided into four lineages, which is mainly based on the sequence variations within the long control region (LCR). 15, 16 Although, naturally occurring LCR sequence variations have been shown to carry different promoter activity in-vitro, 31 two previous studies that analyzed epidemiological risk association based on the LCR-lineage classification system did not reveal any significant differences among the lineages or sub-lineages. 16,18 15 This is special for HPV58 as an association between LCR polymorphisms and lesion has been reported for other types. The current study suggested that the nucleotide sequence variations at E7 are more useful for predicting the risk of HPV58 variants. In-vitro study to compare the transforming activities among E7 proteins carrying these amino acid substitutions is ongoing.
In conclusion, this study provides a comprehensive analysis on the sequence variation of E6
and E7 of HPV58 from a worldwide perspective. E6 is less variable and more appropriate as a target for type-specific diagnostic detection. Geographical variation in the distribution of HPV58 E6 and E7
sequence variations exists, which should be considered when designing diagnostic assays and therapeutic vaccines. Amino acid substitution(s) T20I and/or G63S at E7 is(are) associated with a higher risk for CIN3 and invasive cervical cancer. This high-risk sequence signature is more commonly found in isolates from Asia and the Americas than elsewhere, resembling the geographical predilection of cervical cancers attributed to HPV58.
Legends for figures Figure 1. Nucleotide sequence variations at E6 of 19 HPV58 isolates.
1 The group containing the prototype was assigned as E6-A. The HPV58 prototype (http://www.ncbi.nlm.nih.gov/genbank accession no. NC_001443) was used as reference. 2 No. (%) of each sequence pattern found among the 401 samples examined. 3 Nucleotide positions where variations were detected are written vertically across the top. Sites with no changes are marked with dashes. Capital letters indicate alternations result in an amino acid change. Lower case letters indicate synonymous mutations. 4 The one letter amino acid code is used. The position of amino acid change is stated numerically. The letter preceding this number refers to the reference amino acid, and the letter following refers to its substitution. 5 Lineage and sub-lineage classification based on full genome or concatenated E6-E7-E2-E5-L1-PCR sequences described in previous studies 15, 16 Some E6 sequence patterns are not sub-lineage-specific.
--, no sub-lineage assigned. Single nucleotide substitutions diagnostic for E6 variants are boxed.
GenBank accession numbers for E6 sequences are ## (pending).
Figure 2. Phylogenetic trees of E6 and E7 of HPV58.
The maximum-likelihood trees were constructed by MEGA5 using the close-neighbor-interchange (CNI) search approach. Bootstrap values of ≥ 50% generated by 1,000 resamplings are shown.
A. Constructed from 450-bp E6 nucleotide sequences of 19 HPV58 isolates. The length of scale bar represents 0.004 substitutions per nucleotide position. The sample HK969 with E6 nucleotide sequence identical to the prototype (GenBank accession no. NC_001443) is indicated by an arrow. 18 The group containing the prototype sequence was assigned as E6-A. Sample CAN301 was grouped into sequence pattern E6-A. Italy  17  10  1  3  1  0  2 1 ASCUS, atypical squamous cells of undetermined significance. 2 LGSIL, low-grade squamous intraepithelial lesions, including cervical intraepithelial neoplasia grade 1 (CIN1), and mild dysplasia. 3 HGSIL, high-grade squamous intraepithelial lesions, including CIN2, CIN3, and severe dysplasia. 4 Cervical or vaginal swabs. 5 Anal swab samples. Reference 
B. Constructed from 297-bp
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